Allena Pharmaceuticals, Inc.
ALNAQ · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $20 | $20 | $37 | $26 |
| G&A Expenses | $12 | $12 | $10 | $9 |
| SG&A Expenses | $12 | $12 | $10 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $32 | $32 | $47 | $36 |
| Operating Income | -$32 | -$32 | -$47 | -$36 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$1 | $0 | -$0 |
| Pre-Tax Income | -$33 | -$33 | -$47 | -$36 |
| Tax Expense | $1 | $0 | $0 | -$0 |
| Net Income | -$33 | -$33 | -$47 | -$36 |
| % Margin | – | – | – | – |
| EPS | -1.03 | -1.01 | -2.13 | -1.72 |
| % Growth | -2% | 52.6% | -23.8% | – |
| EPS Diluted | -1.03 | -1.01 | -2.13 | -1.72 |
| Weighted Avg Shares Out | 33 | 33 | 22 | 21 |
| Weighted Avg Shares Out Dil | 33 | 33 | 22 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | -$1 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$32 | -$33 | -$47 | -$36 |
| % Margin | – | – | – | – |